Alleo and Ubiquigent enter AI-driven strategic partnership to accelerate DUB-focused drug discovery
Ubiquigent Limited (“Ubiquigent”), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced a strategic partnership…
Read More...
Read More...